ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : DEMYELINATION
Clear All
Filter by Field of Research
Central Nervous System (6)
Neurology And Neuromuscular Diseases (4)
Neurology and Neuromuscular Diseases (4)
Medical and Health Sciences (2)
Biochemistry and Cell Biology (1)
Cell Development, Proliferation and Death (1)
Cell Neurochemistry (1)
Clinical Sciences not elsewhere classified (1)
Endocrinology (1)
Epidemiology (1)
Medical infection agents (incl. prions) (1)
Oral and maxillofacial surgery (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (39)
Filter by Status
Closed (38)
Filter by Scheme
NHMRC Project Grants (28)
NHMRC Postgraduate Scholarships (4)
Early Career Fellowships (2)
Project Grants (2)
Career Development Fellowships (1)
Ideas Grants (1)
Practitioner Fellowships (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
TAS (1)
VIC (1)
  • Researchers (0)
  • Funded Activities (39)
  • Organisations (0)
  • Funded Activity

    The Role Of PMP-22 As An Autoantigen In GBS 7 CIDP

    Funder
    National Health and Medical Research Council
    Funding Amount
    $44,819.00
    More information
    Funded Activity

    The Role Of Leukemia Inhibitory Factor Signalling In Oligodendrocyte Survival And Limiting Demyelination

    Funder
    National Health and Medical Research Council
    Funding Amount
    $72,969.00
    More information
    Funded Activity

    Recurrences Of Demyelinating Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $85,066.00
    More information
    Funded Activity

    The Effects Of Insulin-like Growth Factor 1 (IGF-1) On Autoimmune Demyelinating Disease In The Mouse

    Funder
    National Health and Medical Research Council
    Funding Amount
    $93,423.00
    More information
    Funded Activity

    Cutting Through Complexity: The Promise Of Biomarkers To Discover, Diagnose, And Treat Antibody-associated Demyelination

    Funder
    National Health and Medical Research Council
    Funding Amount
    $438,768.00
    Summary
    Patients with damage to myelin, the sheath around nerve cells in the brain, have “demyelinating disorders” which can result in severe disability including blindness and paralysis. In some patients, their immune system mistakenly targets certain proteins in the brain. This research project will identify new targets in currently undiagnosed patients, increase our understanding of underlying disease processes, and evaluate optimal treatment strategies in these patients to improve their outcomes.
    More information
    Funded Activity

    Using Non-invasive Magnetic Stimulation To Promote Remyelination

    Funder
    National Health and Medical Research Council
    Funding Amount
    $664,869.00
    Summary
    In patients with multiple sclerosis, brain insulation is lost from nerves. This leads to permanent and progressive disability. We have identified a non-invasive method of magnetic stimulation, and have shown that it increases the number of new insulating cells added to the brain. In this study we will determine whether this new treatment can promote insulation repair in a model of multiple sclerosis.
    More information
    Funded Activity

    Identification And Early Treatment Of Autoimmune Brain Disease In Children

    Funder
    National Health and Medical Research Council
    Funding Amount
    $406,491.00
    Summary
    Acquired brain injury affects 2% of Australians, particularly young people, and can result in permanent disability. Most acquired brain injury is not reversible, however ‘autoimmune brain disease' is due to an overactive immune system and is treatable with modulation of the immune system. By measuring antibodies in the blood, this fellowship will result in early identification and treatment of autoimmune brain disease, and improve outcomes.
    More information
    Funded Activity

    Cell Death In The Nervous System In Demyelinating Disea Se

    Funder
    National Health and Medical Research Council
    Funding Amount
    $253,816.00
    More information
    Funded Activity

    Studies Of Immune Cells In An Animal Model Of Multiple Sclerosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $77,507.00
    More information
    Funded Activity

    Reversing Age-related Impairment Of Myelin Repair - A Novel Therapy For MS

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,053,161.00
    Summary
    Multiple sclerosis (MS) is a disease of the brain and spinal cord caused by the loss of myelin which normally insulates the axons (cables) of nerve cells. When myelin is lost, electrical signals cannot pass along axons normally. Regenerating this myelin is key to restoring normal nerve function but myelin repair deteriorates with age. We will determine whether age-associated decline in myelin repair can be reversed by rejuvenating the myelin repair process.
    More information

    Showing 1-10 of 39 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback